Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720018 · ClinicalTrials.gov registry record · Phase 1
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
A Phase 1 study, sponsored by NuPathe.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00720018: Completed Phase 1 study, sponsored by NuPathe.
NCT00720018 is a Phase 1 study that has completed, run by NuPathe. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00720018, a Phase 1 study, has completed, sponsored by NuPathe.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The primary objective is to compare the pharmacokinetics (PK) profiles among five NP101 patches in healthy volunteers. The secondary objective is to evaluate the safety of NP101 in healthy volunteers.
Interventions
- DRUG NP101 Sumatriptan Iontophoretic Transdermal Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
What the finished NCT00720018 record still lists
NCT00720018 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which NP101 Sumatriptan Iontophoretic Transdermal Patch is the first listed.
NCT00720018 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00720018 about?
NCT00720018 is a clinical study titled "Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers". The primary objective is to compare the pharmacokinetics (PK) profiles among five NP101 patches in healthy volunteers. The secondary objective is to evaluate the safety of NP101 in healthy volunteers.
What is the current status of trial NCT00720018?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2008-06. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00720018?
The interventions under investigation include: NP101 Sumatriptan Iontophoretic Transdermal Patch (DRUG).
Who is sponsoring clinical trial NCT00720018?
This trial is sponsored by NuPathe, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00720018's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia